Recently, a seven-gene m6A/m5C risk model, comprising METTL3, NPLOC4, RBM15, YTHDF1, IGF2BP1, NSUN3, and NSUN7, was developed to stratify the prognosis of early-stage lung cancer.34 This evidence concerns the gene NPLOC4 and lung carcinoma.